225 related articles for article (PubMed ID: 11769675)
81. A patient with myelodysplastic syndrome studied by GTG-banding and fluorescent in situ hybridization (FISH).
Mark HF; Mark Y; Sotomayor E; Sambandam S
Cytobios; 1998; 94(376):121-8. PubMed ID: 9839434
[TBL] [Abstract][Full Text] [Related]
82. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
Zhu Y; Xu W; Liu Q; Pan J; Qiu H; Wang R; Qiao C; Jiang Y; Zhang S; Fan L; Zhang J; Shen Y; Xue Y; Li J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577
[TBL] [Abstract][Full Text] [Related]
83. Efficacy of conventional cytogenetics and FISH for EGR1 to detect deletion 5q in hematological disorders and to assess response to treatment with Lenalidomide.
Zou YS; Fink SR; Stockero KJ; Paternoster SF; Smoley SA; Tun HW; Reeder CB; Tefferi A; Dewald GW
Leuk Res; 2007 Sep; 31(9):1185-9. PubMed ID: 17125835
[TBL] [Abstract][Full Text] [Related]
84. Molecular genetic evidence of Y chromosome loss in male patients with hematological disorders.
Zhang LJ; Shin ES; Yu ZX; Li SB
Chin Med J (Engl); 2007 Nov; 120(22):2002-5. PubMed ID: 18067786
[TBL] [Abstract][Full Text] [Related]
85. Telomere dynamics in myelodysplastic syndrome determined by telomere measurement of marrow metaphases.
Sashida G; Ohyashiki JH; Nakajima A; Sumi M; Kawakubo K; Tauchi T; Ohyashiki K
Clin Cancer Res; 2003 Apr; 9(4):1489-96. PubMed ID: 12684424
[TBL] [Abstract][Full Text] [Related]
86. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category.
Bacher U; Schnittger S; Kern W; Weiss T; Haferlach T; Haferlach C
Ann Hematol; 2009 Dec; 88(12):1207-13. PubMed ID: 19415278
[TBL] [Abstract][Full Text] [Related]
87. Deletion of 5q31 is observed in megakaryocytic cells in patients with myelodysplastic syndromes and a del(5q), including the 5q- syndrome.
Godon C; Talmant P; Garand R; Accart F; Bataille R; Avet-Loiseau H
Genes Chromosomes Cancer; 2000 Dec; 29(4):350-2. PubMed ID: 11066080
[TBL] [Abstract][Full Text] [Related]
88. [Clonal chromosomal aberrations in patients with aplastic anemia at the disease onset and transformation].
Ol'shanskaia IuV; Mikhaĭlova EA; Domracheva EV; Udovichenko AI; Davidian IuR; Vodinskaia LA; Zakharova AV; Kokhno AV; Kaplanskaia IB; Tikhonova LIu; Tsvetaeva NV; Parovichnikova EN; Savchenko VG
Ter Arkh; 2006; 78(7):31-4, 36-7. PubMed ID: 16944748
[TBL] [Abstract][Full Text] [Related]
89. [The application of fluorescence in situ hybridization in detecting chronic myeloid leukemia].
Qiu HR; Miao KR; Wang R; Qiao C; Zhang JF; Zhang SJ; Qian SX; Xu W; Li JY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):207-10. PubMed ID: 19350518
[TBL] [Abstract][Full Text] [Related]
90. [Clinical and experimental study of two cases of myelodysplastic syndromes with double isochromosome 20q- anomaly].
Gong SL; Xue YQ; Wang JM; Han FL; Xu YQ; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):35-8. PubMed ID: 15946507
[TBL] [Abstract][Full Text] [Related]
91. Role of multiplex FISH in identifying chromosome involvement in myelodysplastic syndromes and acute myeloid leukemias with complex karyotypes: a report on 28 cases.
Barouk-Simonet E; Soenen-Cornu V; Roumier C; Cosson A; Laï JL; Fenaux P; Preudhomme C
Cancer Genet Cytogenet; 2005 Mar; 157(2):118-26. PubMed ID: 15721632
[TBL] [Abstract][Full Text] [Related]
92. Treatment of myelodysplastic syndromes with 5q deletion before the lenalidomide era; the GFM experience with EPO and thalidomide.
Kelaidi C; Park S; Brechignac S; Mannone L; Vey N; Dombret H; Aljassem L; Stamatoullas A; Adès L; Giraudier S; de Botton S; Raynaud S; Lepelley P; Picard F; Leroux G; Daniel MT; Bouscary D; Dreyfus F; Fenaux P;
Leuk Res; 2008 Jul; 32(7):1049-53. PubMed ID: 18191202
[TBL] [Abstract][Full Text] [Related]
93. Standardized fluorescence in situ hybridization testing based on an appropriate panel of probes more effectively identifies common cytogenetic abnormalities in myelodysplastic syndromes than conventional cytogenetic analysis: a multicenter prospective study of 2302 patients in China.
Lai YY; Huang XJ; Li J; Zou P; Xu ZF; Sun H; Shao ZH; Zhou DB; Chen FP; Liu ZG; Zhu HL; Wu DP; Wang C; Zhang Y; Li Y; Hou M; Du X; Wang X; Li W; Lai YR; Zhou J; Zhou YH; Fang MY; Qiu L; Wang XM; Zhang GS; Jiang M; Liang YM; Zhang LS; Chen XQ; Bai H; Lin JY
Leuk Res; 2015 May; 39(5):530-5. PubMed ID: 25823643
[TBL] [Abstract][Full Text] [Related]
94. Dihydrofolate reductase activity in the erythroblasts of patients with 5q- syndrome.
Nano R; Invernizzi R; Pecci A; Civallero M; Gerzeli G
Haematologica; 2000 Jul; 85(7):765-6. PubMed ID: 10897132
[No Abstract] [Full Text] [Related]
95. The 2016 revised World Health Organization definition of 'myelodysplastic syndrome with isolated del(5q)'; prognostic implications of single versus double cytogenetic abnormalities.
Gurney M; Patnaik MM; Hanson CA; Litzow MR; Al-Kali A; Ketterling RP; Tefferi A; Gangat N
Br J Haematol; 2017 Jul; 178(1):57-60. PubMed ID: 28419466
[TBL] [Abstract][Full Text] [Related]
96. Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: does -7/7q- detection by FISH have prognostic value?
Ademà V; Hernández JM; Abáigar M; Lumbreras E; Such E; Calull A; Dominguez E; Arenillas L; Mallo M; Cervera J; Marugán I; Tormo M; García F; González T; Luño E; Sanzo C; Martín ML; Fernández M; Costa D; Blázquez B; Barreña B; Marco F; Batlle A; Buño I; Martínez-Laperche C; Noriega V; Collado R; Ivars D; Carbonell F; Vallcorba I; Melero J; Delgado E; Vargas MT; Grau J; Salido M; Espinet B; Melero C; Florensa L; Pedro C; Solé F
Leuk Res; 2013 Apr; 37(4):416-21. PubMed ID: 23337401
[TBL] [Abstract][Full Text] [Related]
97. 5q-: pathogenetic importance of the common deleted region and clinical consequences of the entire deleted segment.
Pedersen B
Anticancer Res; 1993; 13(5C):1913-6. PubMed ID: 8267400
[TBL] [Abstract][Full Text] [Related]
98. Deletion of c-fms sequences in the 5q- syndrome.
Bartram CR; Böhlke JV; Adolph S; Hameister H; Ganser A; Anger B; Heisterkamp N; Groffen J
Leukemia; 1987 Feb; 1(2):146-9. PubMed ID: 3312836
[TBL] [Abstract][Full Text] [Related]
99. Is monosomy 5 an uncommon aberration? Fluorescence in situ hybridization reveals translocations and deletions in myelodysplastic syndromes or acute myelocytic leukemia.
Bram S; Swolin B; Rödjer S; Stockelberg D; Ogärd I; Bäck H
Cancer Genet Cytogenet; 2003 Apr; 142(2):107-14. PubMed ID: 12699885
[TBL] [Abstract][Full Text] [Related]
100. [The 5q(-) syndrome. Report of 2 cases].
Ben Lakhal R; Meddeb B; Gouider E; Aissaoui L; Sannana Sandi H; Ben Abid H; Belhaj Ali Z; Hafsia R; Hafsia A
Tunis Med; 1999 Nov; 77(11):589-92. PubMed ID: 10730148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
